Simposium Endokrinologi Klinik Bandung Ke-XIV

Transkripsi

1 Perkumpulan Endokrinologi Indonesia (PERKENI) Cabang Bandung P E R K E N I Simposium Workshop Pameran Simposium Endokrinologi Klinik Bandung Ke-XIV 5-6 Agustus 2017 Hotel Aryaduta Bandung Theme : Stepping to Improvement Endokrinology Problem in JKN Era SKP IDI Sekretariat Panitia : PT. Traveland Convex Indonesia Jl. Cihampelas 56 B Bandung Phone : , , Fax : , Mobile/Whatsapp: www. endokrinologikl inikbdg.com www. travelandconvex.com

2 Simposium Endokrinologi Klinik Bandung Ke-XIV 2017 Tema : Stepping to Improvement Endokrinology Problem in JKN Era Pengantar Sehubungan dengan kewajiban mensejahterakan bangsa dan meningkatkan pengetahuan sejawat dokter Indonesia untuk mengembangkan ilmu di bidang kedokteran, Perkeni cabang Bandung bekerjasama dengan PT. Traveland Convex Indonesia menyelenggarakan kegiatan Simposium Endokrinologi Klinik Bandung Ke XIV pada tanggal 5-6 Agustus 2017 di Hotel Aryaduta Bandung. Perkeni cabang Bandung menghadirkan para pakar yang akan berbagi ilmu dan pengalaman untuk meningkatkan pengetahuan, serta ketajaman daya analisis untuk menentukan sikap dalam menghadapi masalah-masalah di bidang kedokteran, khususnya bidang Endokrinologi, sehingga dapat meningkatkan kualitas penatalaksanaan penderita di masyarakat Indonesia. Kami mengundang semua pihak yang terkait untuk berpartisipasi agar acara ini berjalan dengan baik dan bermanfaat bagi dunia kesehatan di Indonesia. Penyelenggara, Perkeni cabang Bandung dengan PT Traveland Convex Indonesia.

3 Informasi Umum Simposium Endokrinologi Klinik Bandung Ke-XIV 2017 Tema : Stepping to Improvement Endokrinology Problem in JKN Era Bentuk Acara? 3 Plenary Lecture? 4 Symposium? 2 Pre Lunch Symposium? 2 Lunch Symposium? 7 Workshop Waktu & Tempat Sabtu - Minggu, 5 6 Agustus 2017 Hotel Aryaduta Bandung Jl. Sumatra No. 51 Bandung Rekening Panitia An. TRAVELAND CONVEX INDONESIA Bank BCA KCU ASIA AFRIKA No Rek Topics : - Optimizing Referal System of Endocrine Problems in JKN Era - Is All Anti Thyroid Drug The Same - Management of Adrenal Insufficiency: The Role of IV Hydrocortisone - Risk Factors for Dementia in Patients with DM. - Insulin Update & GLP 1 Update - New Treatment to Help Your Type 2 Diabetes Patients - Nephrodiabetic Treatment - Insulin Therapy: Practical Case on Initiation and Intensification. - Achieving Antihyperglycemic Treatment Goal with New Invention on Incretin Based Therapies - Synchronizing Diabetes Treatment Approaches to Needs - New Frontiers in the Management of Hypertension and Metabolic Disease - The New Horizon in Type-2 Diabetes Mellitus Management Workshops: 1. Advances & Lessons Learned from the Clinicians 2. Advancing Dyslipidemia Management in Patients with T2DM 3. Optimized Glucose-Lowering Control with Modified Release Gliclazide Formulation 4. How to Monitor Your Patient's Glycemic Condition? 5. Get to Target in Diabetes : Optimizing Dose of Metformin and Importance of Achieving Target HbA1C 6. Management of Hypoglycemia in T2DM Therapy 7. New Paradigm of T2DM - from 2017 Guideline to Real Practice

4 AGENDA ACARA H-1 KLINIK BANDUNG XIV 2017 Sabtu, 5 Agustus 2017 WAKTU Re-registration Opening Ceremony PLENARY LECTURE I : TOPIK Optimizing Referal System of Endocrine Problems in JKN Era SYMPOSIUM I : Insulin Update & GLP 1 Update The role of GLP-1 in type 2 diabetes Achieve optimal glycaemic control with insulin therapy Coffee Break PRE LUNCH SYMPOSIUM I : Achieving Antihyperglycemic Greatment Goal with New Invention on Incretin Based Therapies Are all DPP4 inhibitors the same? Introducing sitagliptin - extended released metformin: The power to lower HbA1c PLENARY LECTURE II : : Is All Anti Thyroid Drug The Same Hyperthyroidism: how can we manage it better LUNCH SYMPOSIUM I: New Frontiers in the Management of Hypertension and Metabolic Disease A closer look of linagliptin ~ The novel DPP4-inhibitor with a broad action & powerful efficacy in T2DM management Lunch PEMBICARA / MODERATOR Mod: Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM Prof. Dr. Achmad Rudijanto, dr.,sppd-kemd.finasim Mod : Prof. Dr. Achmad Rudijanto, dr., SpPD-KEMD.FINASIM Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM Mod: Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM dr. Putu Moda Arsana, SpPD-KEMD.FINASIM Mod : Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM Prof. Dr. Johan S. Masjhur, dr., SpPD-KEMD., SpKN. Prof. Dr. Johan S Masjhur, dr.,sppd-kemd.spkn Mod : Augusta YL Arifin, dr.,sppd-kemd.finasim The powerful 24 hr BP reductions with single pill combination: Prof. Dr. Rully MA Roesli, dr., SpPD-KGH.FINASIM focus on telmisartan + amlodipine

5 AGENDA ACARA H-1 KLINIK BANDUNG XIV 2017 Sabtu, 5 Agustus 2017 WAKTU TOPIK SYMPOSIUM II : New Treatment to Help Your Type 2 Diabetes Patients Why do we need SGLT-2 inhibitors and how do they work? What are the key clinical data and local experience for dapagliflozin? Coffee Break SYMPOSIUM III : Nephrodiabetic Treatment Early done combination approach the reason behind, focus on glimepiride + metformin Nutritional management in diabetic nefropathy: effect of ketoacid on progression in diabetic nefropathy PARALLEL WORKSHOP WORKSHOP 1 : Advances & Lessons Learned from the Clinicians - The importance of 24 hour BP control for managing CV risk - Clinical advances in DPP4 inhibitor treatment for The management of T2DM WORKSHOP 2 : Advancing Dyslipidemia Management in Patients with T2DM - Management of dyslipidemia in T2DM patients : patients still need therapy without target? - Prevention of CVD in T2DM patients: which is more important decrease in LDL or glucosede? WORKSHOP 3 : Optimized Glucose-Lowering Control with Modified Release Gliclazide Formulation - Role of gliclazide MR Today, an efficacy and safety you can trust - Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON WORKSHOP 4 : How to Monitor Your Patient's Glycemic Condition? - How to use SMBG wisely in your diabetic patients? - When to measure HbA1c or Glycated Albumin wisely for your diabetic patients? PEMBICARA / MODERATOR Mod : Augusta YL Arifin, dr.,sppd-kemd.finasim Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM Octo Indradjaja, dr., SpPD-KEMD.FINASIM Mod : Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM Rubin Surachno Gondodiputro, dr., SpPD-KGH.FINASIM Rubin Surachno Gondodiputro, dr., SpPD-KGH.FINASIM Augusta YL Arifin, dr.,sppd-kemd.finasim Maya Kusumawati, dr.,sppd Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM Octo Indradjaja, dr., SpPD-KEMD.FINASIM Miftahurachman, dr., SpPD-KEMD.M.Kes,FINASIM Hoo Yumilia, dr., SpPD-KEMD.FINASIM

6 AGENDA ACARA H-2 KLINIK BANDUNG XIV 2017 Minggu, 6 Agustus 2017 WAKTU Re-registration MEDICOLEGAL SESSION TOPIK Insulin Initiation: Premix or Long Acting insulin? Miftahurachman, dr., SpPD-KEMD.M.Kes.FINASIM insulin Intensification: When Simple Injection does not Control Blood Glucose Dr. Hikmat Permana, dr.,sppd-kemd.finasim Prof. Dr. Johan S Masjhur, dr.,sppd-kemd.spkn PRE LUNCH SYMPOSIUM II : Mod : Dr. Hikmat Permana, dr.,sppd-kemd.finasim Synchronizing Diabetes Treatment Approaches To Needs Addressing the unmet need of basal insulin therapy in diabetes patient Augusta YL Arifin, dr.,sppd-kemd, FINASIM Overview the next generation of basal insulin in diabetes management: Translating pharmacokinetic profile into clinical practice PLENARY LECTURE III Management of Adrenal Insufficiency: the Role of IV Hydrocortisone Risk Factors for Dementia in Patients with DM Coffee Break SYMPOSIUM IV : Insulin Therapy: Practical Case on initiation and intensification LUNCH SYMPOSIUM II : The New Horizon In Type-2 Diabetes Mellitus Management Synergistic Effects (Saxagliptin + Metformin-XR) in Aggressive Treatment of T2DM Innovation of Biosimilar Basal Insulin in Type-2 Diabetes Management PEMBICARA / MODERATOR Medicolegal Tim BHP2A IDI Wilayah Jawa Barat Mod : Augusta YL Arifin, dr., SpPD-KEMD.FINASIM Dr. Hikmat Permana, dr., SpPD-KEMD.FINASIM Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM Mod: Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM Mod: Prof. Dr. Sri Hartini KS Kariadi, dr., SpPD-KEMD.FINASIM Augusta YL Arifin, dr., SpPD-KEMD.FINASIM Hoo Yumilia, dr., SpPD-KEMD.FINASIM

7 AGENDA ACARA H-2 KLINIK BANDUNG XIV 2017 Minggu, 6 Agustus 2017 WAKTU Lunch PARALLEL WORKSHOP TOPIK WORKSHOP 5 : Get to Target in Diabetes : Optimizing Dose of Metformin and Importance of Achieving Target HbA1C PEMBICARA / MODERATOR Prof. Dr. Johan S Masjhur, dr.,sppd-kemd.spkn Optimizing benefit of T2DM patients with optimal dose of metformin Fixed dose combination in Type-2 Diabetes Management What we need to know? WORKSHOP 6 : Management of Hypoglicemia in T2DM Theraphy A Call a Call to action for hypoglycemia risk in type 2 DMT2 Therapy : how to manage it? The new paradigm: the role of DPP4 - Inhibitor in combination with insulin for hight risk hypoglycemia WORKSHOP 7 : New Paradigm of T2DM - from 2017 Guideline to Real Practice Current Burden and Management updates of Type 2 Diabetes Mellitus How to implement Insulin-Independent Therapy in daily clinical practice Ervita, dr.,sppd.m.kes Hoo Yumilia, dr.,sppd-kemd.finasim Miftahurachman, dr.,sppd-kemd.m.kes.finasim Octo Indradjaja, dr.,sppd-kemd.finasim Dr. Hikmat Permana, dr.,sppd-kemd.finasim

8 Simposium Endokrinologi Klinik Bandung Ke-XIV Stepping to Improvement Endokronology Problem in JKN Era 5-6 Agustus 2017 Hotel Aryaduta Bandung FORMULIR PENDAFTARAN No Registration : Nama Alamat Kota Telepon Mobile Phone Fax Pendaftaran Sebelum Sesudah (Simposium & Workshop) 15 Juli Juli 2017 Dokter Spesialis Rp 2,000,000,- Rp 2,500,000,- Dokter Umum Rp 1,250,000,- Rp 1,500,000,- Hotel Aryaduta Bandung Check in date Check out date Qty Room Type Kamar Superior Room IDR 950,000 /night Sudah termasuk sarapan pagi untuk 2 Orang Hotel Total Rp. Rp. Registrasi Rp. Sekretariat Panitia : PT. Traveland Convex Indonesia Jl. Cihampelas 56 B Bandung Phone : , Fax : Mobile/Whatsapp: www. endokrinologiklinikbdg.com Contact Person : Eva : Pendaftar Biaya Pendaftaran dapat di transferred ke : An. TRAVELAND CONVEX INDONESIA Bank BCA KCU ASIA AFRIKA No Rek